Present studies of glioma are conflicting because the P53 pathway functions in many different cellular responses, such as cell cycle regulation, apoptosis, differentiation, and DNA damage response, and the prognostic and predictive response of this protein in glioma recurrence is still largely undetermined (34). Here, TP53 is linked to central nervous system cancer.